Quick definitions for the most commonly misunderstood terms in cell culture, DMPK transporter assays and bioprocessing — written for researchers, DMPK scientists and procurement teams.
| Term |
One-line definition |
Full guide |
| FBS (Fetal Bovine Serum) |
The most widely used cell culture supplement — blood serum collected from bovine fetuses, providing growth factors, albumin and nutrients to support cell growth. |
Read → |
| Heat Inactivated FBS |
FBS heated to 56°C for 30 minutes to destroy complement proteins — used in embryo culture, PBMC assays and virus neutralisation. |
Read → |
| Geringer Endotoxingehalt FBS |
FBS tested to <1 EU/mL endotoxin — required for drug screening, AAV production and cytokine assays where LPS would confound results. |
Read → |
| Lysat aus menschlichen Blutplättchen (hPL) |
A xeno-free, human-derived FBS alternative produced by freeze-thaw lysis of platelets — releasing concentrated PDGF, EGF, TGF-β and IGF-1 for MSC and primary cell culture. |
Read → |
| Off-the-Clot (OTC) Serum |
Human serum produced by natural clotting — platelets fully activate and release growth factors, giving higher PDGF and EGF than standard plasma-derived serum. |
Read → |
| Term |
One-line definition |
Full guide |
| BSEP (Bile Salt Export Pump) |
The primary hepatocyte canalicular transporter for bile salt secretion — BSEP inhibition causes intracellular bile salt accumulation and is the leading mechanism of cholestatic drug-induced liver injury (DILI). |
Read → |
| P-glycoprotein (P-gp / MDR1 / ABCB1) |
An ABC efflux transporter expressed at the intestinal epithelium, blood-brain barrier and liver — limits oral bioavailability and CNS penetration; mandatory DDI testing for all NMEs under FDA, EMA and ICH M12. |
Read → |
| Vesicular Transport Assay |
An in vitro method using inside-out membrane vesicles to measure ABC transporter substrate accumulation and inhibitor IC50 — the only viable method for BSEP, MRP2, MRP3, MRP4 where no cell monolayer model exists. |
Read → |
| DILI (Drug-Induced Liver Injury) |
Hepatotoxicity caused by a drug or supplement — the leading cause of post-marketing drug withdrawal. BSEP inhibition is the primary mechanism of cholestatic DILI. |
Read → |